header-pp-disease-areas_02.gif
Genetic variation often determines the success of treatment. Results from predictive biomarker testing, by definition, determines how a person will respond to targeted treatment. These test results enable you, the physician, to tailor treatment to achieve the best possible outcome for your patient.
Personalized Molecular Medicine is a proven proactive approach that provides critical information to empower you to consult with your patient with a more complete understanding of disease status, so you can make the best informed choices and ensure the best possible outcome.

Medical Conditions

Everyone’s disease is different; both because the molecular basis of disease varies from one individual to another and because the genetics of each individual are different. Further, each person metabolizes and utilizes (or often fails to utilize) drugs that are routinely prescribed for various diseases. 

Leukemia
Leukemia is a cancer of cells in the bone marrow and blood. These malignant cells proliferate and accumulate in the blood and within organs of the body, crowding out and interfering with the normal functions of blood cells. There are four categories of leukemia. Two of the names signify the lineage or type of blood cell that has become malignant (myelogenous and lymphocytic). The other two names, acute or chronic, refer to the forms of the disease to further characterize the type and behavior of the cancer. Lymphocytic or lymphoblastic leukemias arise from cells in the bone marrow that normally produce lymphocytes. Myelogenous or myeloid leukemias arise from cells in the bone marrow that normally give rise to red cells, some types of white cells, and platelets.

Acute Myelogenous Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Chronic Myelogenous Leukemia (CML)
Chronic Lymphocytic Leukemia (CLL)

 

Hairy Cell Leukemia
All Products for Leukemia

Lymphoma
Lymphoma is a group of cancers that affect the cells that play a role in the immune system, and primarily represents cells involved in the lymphatic system of the body. Lymphoma is a malignant transformation of either lymphocytes B or T cells or their subtypes. Lymphomas fall into 1 of 2 major categories. Hodgkin lymphoma (HL, previously called Hodgkin's disease) and all other lymphomas (non-Hodgkin lymphomas or NHLs).

Hodgkin Lymphoma (HL)
Non-Hodgkin Lymphomas (NHLs)

Other Medical Conditions
Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders


 

Notice: Acute Myeloid Leukemia (AML)
The FDA has made it clear that a FLT3 companion diagnostic is required for approval of any FLT3-targeted or FLT3-stratified therapy. LabPMM is the only clinical laboratory with access to the patents required to develop and offer a FLT3 companion diagnostic for worldwide use(excluding Japan).


Invivoscribe Companies

h-labPMM-logo.gif h-amlalliance.gif ivs-labflow.gifh-ivs-sarl.gif